Golden
Anviro Therapeutics

Anviro Therapeutics

Anviro Therapeutics is a biotechnology company developing broad spectrum antiviral therapies.

All edits

Edits on 25 Jul 2019
Will Suter
Will Suter approved a suggestion from Golden's AI on 25 Jul 2019 1:44 am
Edits made to:
Article (+13/-13 characters)

Article

Anviro Therapeutics is a privately held, biotechnology company making broad-spectrum antiviral therapeutics that is based in Orem, Utah and was founded in 2015 by Kyle Lane and Matthew CryerMatthew Cryer. The company is developing treatments for several infectious diseases, including pox viruses and herpes viruses. Their lead program is based on technology discovered by researchers at Brigham Young University (BYU). 

Golden AI
Golden AI edited on 24 Jul 2019 12:03 pm
Edits made to:
Infobox (+1 properties)
Edits on 30 May 2019
Jan Stepnicka
Jan Stepnicka approved a suggestion from Golden's AI on 30 May 2019 1:35 pm
Edits made to:
Article (+9/-9 characters)

Article

Anviro Therapeutics is a privately held, biotechnology company making broad-spectrum antiviral therapeutics that is based in Orem, Utah and was founded in 2015 by Kyle LaneKyle Lane and Matthew Cryer. The company is developing treatments for several infectious diseases, including pox viruses and herpes viruses. Their lead program is based on technology discovered by researchers at Brigham Young University (BYU). 

Edits on 30 May 2019
Golden AI
Golden AI edited on 30 May 2019 4:53 am
Edits made to:
Infobox (+1 properties)

Infobox

Founder
Edits on 28 Mar 2019
Dawson Sewell
Dawson Sewell edited on 28 Mar 2019 9:57 pm
Edits made to:
Infobox (+3/-1 properties)
Timeline (+2 events) (+242 characters)
Description (+94/-26 characters)
Article (+249/-12 characters)
Categories (+1/-2 topics)
Related Topics (+1 topics)
Topic thumbnail

Anviro Therapeutics

Antiherpes therapy company

Anviro Therapeutics is a biotechnology company developing broad spectrum antiviral therapies.

Article

Anviro Therapeutics is a privately held, biotechnology company making broad-spectrum antiviral companytherapeutics that is based in Orem, Utah and was founded in 2015 by Kyle Lane and Matthew Cryer. The company is developing treatments for several infectious diseases, including pox viruses and herpes viruses. Their lead program is based on technology discovered by researchers at Brigham Young University (BYU). 

...

In virtovitro and in vivo assays have shown potential for KPB-100 as a topical treatment for several DNA-viruses, including:

...



Funding

Seed

On January 1, 2016 Anviro Therapeutics completed their seed funding round with $650,000 in funding from undisclosed investors. 

Infobox

Categories

Related Topics

Timeline

2016

Seed funding

On January 1, 2016 Anviro Therapeutics completed their seed funding round with $650,000 in funding from undisclosed investors. 

March 28, 2015

Founding of Anviro Therapeutics

Anviro Therapeutics was founded in 2015 by Kyle Lane and Matthew Cryer.

Edits on 4 Feb 2019
Golden AI"Import data"
Golden AI edited on 4 Feb 2019 10:54 pm
Edits made to:
Infobox (+1 properties)
People (+1 rows) (+2 cells) (+15 characters)

People

Name
Role
Related Golden topics

Tom Fast

Advisor



Infobox

Industry
Edits on 21 Jan 2019
Golden AI"Changed markets to industries"
Golden AI edited on 21 Jan 2019 10:17 pm
Edits made to:
Infobox (+3/-3 properties)
Edits on 15 Jan 2019
Dawson Sewell
Dawson Sewell approved a suggestion from Golden's AI on 15 Jan 2019 2:12 pm
Edits made to:
Article (+24/-24 characters)

Article

Anviro Therapeutics is a privately held, broad-spectrum antiviral company based in Orem, Utah. The company is developing treatments for several infectious diseases, including pox viruses and herpes viruses. Their lead program is based on technology discovered by researchers at Brigham Young UniversityBrigham Young University (BYU). 

Edits on 10 Jan 2019
Golden AI
Golden AI edited on 10 Jan 2019 10:19 am
Edits made to:
Infobox (+1 properties)

Infobox

Jude Gomila
Jude Gomila approved a suggestion from Golden's AI on 9 Jan 2019 8:49 pm
Edits made to:
Article (+10/-10 characters)

Article

Anviro Therapeutics is a privately held, broad-spectrum antiviral company based in Orem, UtahOrem, Utah. The company is developing treatments for several infectious diseases, including pox viruses and herpes viruses. Their lead program is based on technology discovered by researchers at Brigham Young University (BYU). 

Edits on 6 Jan 2019
Sameeha Sulaiman
Sameeha Sulaiman edited on 6 Jan 2019 8:07 pm
Edits made to:
Infobox (+2/-2 properties)
Article (+1200 characters)
People (+1 rows) (+2 cells) (+53/-16 characters)

Article

Anviro Therapeutics is a privately held, broad-spectrum antiviral company based in Orem, Utah. The company is developing treatments for several infectious diseases, including pox viruses and herpes viruses. Their lead program is based on technology discovered by researchers at Brigham Young University (BYU). 



The compound, designated KPB-100, has antiviral properties across a range of viruses in the herpes and pox virus families. KPB-100 is a small molecule that utilizes a mechanism of action directed at morphogenesis inhibition, which allows it to be used as a treatment against strains of the herpes virus that are resistant to frontline treatments.



In virto and in vivo assays have shown potential for KPB-100 as a topical treatment for several DNA-viruses, including:

  • Wildtype and mutant HSV-1 and HSV-2
  • Herpes zoster (shingles)
  • Progressive vaccinia
  • Adverse effects of smallpox vaccination



Anviro's expected timeline for the product is as follows:

  • 2018 - Submission of Investigational New Drug (IND) Application to the USFDA
  • 2018 - 2019 - Small Scale Clinical Trial (Phase 1)
  • 2020 - 2023 - Large Scale Clinical Trial (Phase 2)
  • 2023 - 2025 - Comparative Clinical Trial (Phase 3)
  • 2026 - Commercial Launch

People

Name
Role
Related Golden topics

Kyle Lane

EmployeeCOO



Marc Hansen

EmployeeActing Chief Scientific Officer



Mark Elder

CFO



Matthew Cryer

Founder & CEO



Infobox

Edits on 12 Dec 2018
Golden AI"Import data"
Golden AI edited on 12 Dec 2018 1:05 am
Edits made to:
Infobox (+1 properties)
People (+4 rows) (+8 cells) (+77 characters)
Categories (+1 topics)

People

Name
Role
Related Golden topics

Alonzo Cook

Employee



Kyle Lane

Employee



Marc Hansen

Employee



Merritt Andrus

Employee



Infobox

Categories

Edits on 14 Nov 2018
Melanie Manipula"Approved suggestion from source: http://anvirotherapeutics.com"
Melanie Manipula approved a suggestion from Golden's AI on 14 Nov 2018 9:30 pm
Edits made to:
Infobox (+1 properties)
Edits on 14 Nov 2018
Jude Gomila"Approved suggestion from source: http://anvirotherapeutics.com"
Jude Gomila approved a suggestion from Golden's AI on 14 Nov 2018 3:12 am
Edits made to:
Infobox (+1 properties)
Edits on 19 Jul 2018
Golden AI"Update locations in infobox"
Golden AI edited on 19 Jul 2018 8:46 pm

Infobox

Location
Golden AI"Update locations in infobox"
Golden AI edited on 19 Jul 2018 8:42 pm

Infobox

Location
Edits on 16 Jul 2018
Golden AI"Update markets in infobox"
Golden AI edited on 16 Jul 2018 11:35 pm
Edits on 29 Jun 2018
Golden AI"Update infobox"
Golden AI edited on 29 Jun 2018 5:35 pm
Edits on 18 Jun 2018
Golden AI"Updating description"
Golden AI edited on 18 Jun 2018 10:51 pm
Edits made to:
Description (+10/-16 characters)
Topic thumbnail

Anviro Therapeutics

Novel antiherpesAntiherpes therapy company

Golden AI"Updating description"
Golden AI edited on 18 Jun 2018 10:50 pm
Edits made to:
Description (+16/-10 characters)
Topic thumbnail

Anviro Therapeutics

AntiherpesNovel antiherpes therapy company